Current Position: Product Center
Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)
Cat. No.
GM-87988MAB
Size
Quote
Related products
Product Info
Cat. No. & Size
Description
Data
Related products
Product Info

Cat. No.:GM-87988MAB

Product:Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)

Cat. No. & Size

GM-87988MAB-1mg / 1 mg

GM-87988MAB-5mg / 5 mg

GM-87988MAB-25mg / 5 mg * 5 vials

GM-87988MAB-50mg / 50 mg

GM-87988MAB-100mg / 50 mg * 2 vials


Description

Expression System      CHO

Aggregation                < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                      0.2 μm Filtered

Target                          Integrin α4β7

Clone                               Vedolizumab

Alternative Names         Lymphocyte Peyer’s patch adhesion molecule-1 (LPAM-1)

Source/Isotype           Monoclonal Human IgG1(KDEL), Kappa

Application                      /

Description                 Vedolizumab is a selective monoclonal antibody targeting integrin α4β7.By blocking the interaction between integrin α4β7 and MadCAM-1, itreduces the accumulation of inflammatory lymphocytes in the intestinalmucosa, thereby suppressing intestinal inflammation while preservingsystemic immune function.

Formulation                phosphate-buffered solution, pH 7.2-7.4.


Data

image.png

image.png


Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)
Cat. No.
GM-87988MAB
Size
Quote
Related products
Product Info
Cat. No. & Size
Description
Data
Related products
Product Info

Cat. No.:GM-87988MAB

Product:Anti-Integrin α4β7 hIgG1 Reference Antibody (Vedobio)

Cat. No. & Size

GM-87988MAB-1mg / 1 mg

GM-87988MAB-5mg / 5 mg

GM-87988MAB-25mg / 5 mg * 5 vials

GM-87988MAB-50mg / 50 mg

GM-87988MAB-100mg / 50 mg * 2 vials


Description

Expression System      CHO

Aggregation                < 5% as determined by SEC-HPLC

Purity                           > 95% as determined by SDS-PAGE

Endotoxin                    < 1 EU/mg, determined by LAL gel clotting assay

Sterility                      0.2 μm Filtered

Target                          Integrin α4β7

Clone                               Vedolizumab

Alternative Names         Lymphocyte Peyer’s patch adhesion molecule-1 (LPAM-1)

Source/Isotype           Monoclonal Human IgG1(KDEL), Kappa

Application                      /

Description                 Vedolizumab is a selective monoclonal antibody targeting integrin α4β7.By blocking the interaction between integrin α4β7 and MadCAM-1, itreduces the accumulation of inflammatory lymphocytes in the intestinalmucosa, thereby suppressing intestinal inflammation while preservingsystemic immune function.

Formulation                phosphate-buffered solution, pH 7.2-7.4.


Data

image.png

image.png


Message consultation
reset
submit
Message
Message consultation
reset
submit